Multimedia

news
Multimedia

Multimedia

Foto's

Bekijk alle foto's hier

Video's

Kristel De Gauquier - Medical Director pharma.be : "Zeldzame ziekten : uitdaging voor de farma sector"
Video van de informatiecampagne #WijGevenNietOp
Catherine Rutten, CEO pharma.be, spreekt over de #WijGevenNietOp informatiecampagne.
Clinical Trial Forum Part II - Interviews with Catherine Rutten (CEO pharma.be), Liesbeth Moortgat (AS Delta), PR. Sylvie Rottey (UZ Ghent).
Clinical Trial Forum - Part I - Interviews with Catherine Rutten (CEO pharma.be), Jean-Pierre Latere (Celyad), PR. François Duhoux (UCL St Luc)
Compilation movie - pharma.be Dialogue 2017
Dialogue 2017: interview with Manuella Wilts. Director costumer services EMEA Johnson&Johnson
Dialogue 2017: interview with Herman De Croo. Minister of State
Dialogue 2017: interview with Sonja Willems. Chairwoman pharma.be.
Dialogue 2017: interview with Dirk Lannoo. V.P. Katoen Natie.
Dialogue 2017: interview with Gert Bervoets. CEO ESSERS.
Dialogue 2017: interview with Pascale Delcomminette. CEO Wallonia Foreign Trade and Investment Agency (AWEX)
Dialogue 2017: interview Catherine Rutten. CEO pharma.be.
N-SIDE: bringing forecasting, simulation & optimization solutions to pharma
Lieven Zwaenepoel (APB): Digital innovation in community pharmacies
Federal Agency inspections for quality and safe medicines (famhp)
The journey of a medicine: from production to delivery to patients
Dr. Isabelle Huyghe, Senior Clinical Research physician at Pfizer, describing the importance of clinical trials and volunteering.
Mario, a clinical trial volunteer, about his motivations to participate to a clinical trial study.
Anna Colzi, Medical Director at Pfizer's phase 1 unit at the Erasmus hospital in Brussels, is describing the patients" engagement to clinical trials.
50 years of pharma.be Symposium (compilation)
"New perspectives in Hepatitis C treatment" - Véronique Scaillon
"Improved quality of life of Psoriasis patients" - Paul De Corte
"Innovations give hope to pancreatic cancer patients" - Leo Coene
"How HIV became a treatable, chronic disease" - Patrick Reyntiens
Xavier De Cuyper (famhp) : "Preserving the Belgian leadership in clinical trials in Europe"
Facts & figures on the Belgian Pharma Valley
Belgium's contribution to therapeutic innovation through the past decades
Proud to be part of pharma : Francis' role within Zoetis, is development and production of new vaccines for animals. Follow on Twitter: #pharmafaces
"Proud to be part of pharma" : Tom (AbbVie) looks to develop new,innovative solutions to support patients with chronic diseases in their treatment process. Follow on Twitter: #pharmafaces
"Proud to be part of pharma" : After a five-year career as a general practitioner, Dr. Paul Lacante made the switch to the pharmaceutical industry and is now Medical Director. Follow on Twitter: #pharmafaces
"Proud to be part of pharma" : Ingrid (UCB) works closely with a team of MSL's that gives scientific support to physicians. Follow on Twitter : #pharmafaces
Nathan De Valck works for the Brussels Airport Company in the Cargo Management team. Brussels Airport stands out for its dedicated infrastructure to transport medicines. Follow on Twitter : #pharmafaces
"Proud to be part of pharma" : Alain-Geert works in the production department of Genzyme, a biotech company that is part of Sanofi. Follow on Twitter : #pharmafaces
"Proud to be part of pharma" : Ellen is a Customer Service Representative at Pfizer. Her objective is to deliver innovative medicines as quick as possible to patients in need, worldwide. Follow on Twitter : #pharmafaces
"Proud to be part of pharma" : As a Market Access Manager for GSK, Catheline acts after a medicine has been registered. She is responsible for submitting applications for price & reimbursement. Follow on Twitter : #pharmafaces
"Proud to be part of pharma" : Working as a Regulatory Affairs Manager for the pharmaceutical company MSD Belgium, Laurence is responsible for the approval process of the registration of new medicines. follow on Twitter : #pharmafaces
"Proud to be part of pharma" : Anne-Sophie is a Clinical Research Associate (CRA) for the pharmaceutical company Novo Nordisk. Her main task is to start up, follow up and close clinical trials. follow on Twitter : #pharmafaces
"Proud to be part of pharma" : Ole works for Janssen Pharmaceutica in Belgium, as a Principal Research Scientist in the R&D group. His expertise lies mainly in the world of personalised pharmaceutical development. Follow on Twitter : #pharmafaces
Catherine Rutten, CEO pharma.be - speech at Dialogue @pharma.be 2016
Interview with Sjaak De Boer (Cordaid) at the Dialogue @pharma.be 2016
Interview with Prof. dr. Marleen Temmerman at the Dialogue @pharma.be 2016
Interview with Eduardo Pisani @ the Dialogue @pharma.be 2016
Interview with Jaak Peeters (J&J) at the Dialogue @pharma.be 2016
Sonja Willems, Chairwoman of the Board of pharma.be - speech at the Dialogue @pharma.be 2016
Dialogue @pharma.be 2016 (produced by Mevipro)
Luc Debruyne, President & General Manager of GSK Vaccines - speech at the Dialogue @pharma.be 2016
Interview with An-Heleen De Greef, Philanthropy Manager, Doctors of the World Belgium
Interview with Sam Proesmans, Doctor in Internal Medicine
Interview with Dr Adrian Hopkins, Director Mectizan Donation Program
Interview with Dr Dirk Teuwen, VP Corporate Societal Responsibility, UCB
Interview with Michael Leniere, Project Lead Supply Chain Pfizer
Interview with Dr Dirk D'Hooge , Medical Director Novo Nordisk Pharma
LEEM: Waarom deelnemen aan een klinische studie?
Op 11 juni 2015 organiseerde het MLOZ (Onafhankelijke Ziekenfondsen) een debat over 'Geneesmiddelen, tegen elke prijs?'. Tijdens dit debat wees Catherine Rutten, CEO van pharma.be, op de hoge ontwikkelingskosten om een geneesmiddel op de markt te brengen en de lage prijzen van geneesmiddelen in België in vergelijking met andere landen in Europa.
Catherine Rutten: ‘Pole position voor klinische research behouden’
Catherine Rutten: ‘Geneesmiddelen sneller op de markt krijgen’
Catherine Rutten (pharma.be): ‘Debat over prijs van geneesmiddelen moet breder’
2015 IFPMA Pharma By Numbers
EFPIA: What Is The Innovative Medicines Initiative? (IMI)
EFPIA: Transparency and Privacy
EFPIA: Clinical Trials and Transparency
EFPIA: The importance of Clinical Trials
EFPIA: Designing a Clinical Trial
EFPIA: The Journey of Clinical Trials
IFPMA video on awareness of fake medicines
EFPIA video: Intellectual Property & the Pharma Industry - Introducing Marty the Medicine
Therapietrouw en goed gebruik van geneesmiddelen